CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Planned sale President and CEO sold 90,474 shares at $15.00 ($1,357,110)
- 4 Option exercise Chief Financial Officer acquired 25,000 shares (option exercise)
- 4 Open-market buy 10% owner bought 2,791,930 shares at $8.00 ($22,335,440)
- 4 Planned sale Chief Financial Officer sold 17,146 shares at $9.00 ($154,314)
- 4 Planned sale President and CEO sold 48,366 shares at $5.78 ($279,555)
- 4 Grant or award Director acquired 16,115 shares (grant or award)
- 4 Grant or award Director acquired 16,115 shares (grant or award)
- 4 Grant or award Director acquired 16,115 shares (grant or award)
- 4 Grant or award Director acquired 16,115 shares (grant or award)
- 4 Grant or award Director acquired 32,230 shares (grant or award)
- 4 Grant or award Director acquired 16,115 shares (grant or award)
- 4 Grant or award Director acquired 32,230 shares (grant or award)
- 4 Grant or award Director acquired 16,115 shares (grant or award)
- 4 Option exercise See Remarks acquired 68,210 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 15,630 shares at $6.17 ($96,421)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 3,300,000 shares at $5.00 ($16,500,000)
Page 4 of 14 · 274 filings